Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - iobenguane (123i) sulfate, quantity: 100 mbq/ml - injection, solution - excipient ingredients: monobasic sodium phosphate dihydrate; dibasic sodium phosphate; ascorbic acid; benzyl alcohol; water for injections - diagnostic scintigraphic localisation of phaeochromocytomas, paragangliomas (chemodectomas), ganglioneuroblastomas and ganglioneuromas. detection, staging and follow-up on therapy of neuroblastomas.

Ireland - English - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - iobenguane - solution for injection - 74 megabecquerel(s)/millilitre - other diagnostic radiopharmaceuticals for tumour detection; iobenguane (123i)

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium iodide(123i) -

European Union - English - EMA (European Medicines Agency)

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 100 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 1 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

curium belgium s.p.r.l.-b.v.b.a. - sodium iodide (123 i) 37 mbq/ml - solution for injection - 37 mbq/ml - sodium iodide (i-123) 37 mbq/ml - sodium iodide (123i)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ge healthcare bv-srl - sodium iodide (123 i) - capsule, hard - 3,7-37 mbq - sodium iodide (i-123) - sodium iodide (123i)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ge healthcare bv-srl - sodium iodide (123 i) 37 mbq/ml - solution for injection - 37 mbq/ml - sodium iodide (i-123) 37 mbq/ml - sodium iodide (123i)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rotop radiopharmacy gmbh - sodium iodide (123 i) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)